Initial Findings of an Open-Label Trial of Low-Dose Naltrexone for Symptomatic Mesenteric Panniculitis.
*Department of Medicine ‡Center for the Study of Complex Diseases NorthShore University HealthSystem Evanston §Department of Gastroenterology NorthShore University HealthSystem Skokie †Department of Biology, Loyola University Chicago, Chicago, IL.
Grigory
G
Roginsky
Aimee
A
Alexoff
Eli D
ED
Ehrenpreis
D000328:Adult; D004305:Dose-Response Relationship, Drug; D006801:Humans; D009271:Naltrexone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D009292:Narcotic Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D015436:Panniculitis, Peritoneal / Q000188:drug therapy* / Q000503:physiopathology; D010865:Pilot Projects; D016896:Treatment Outcome
D009292:Narcotic Antagonists; D009271:Naltrexone